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Newly synthesized proteins and lipids are transported across the
Golgi complex via different mechanisms whose respective roles are
not completely clear.We previously identified a non-vesicular intra-
Golgi transport pathway for glucosylceramide (GlcCer)—the com-
mon precursor of the different series of glycosphingolipids—that is
operated by the cytosolic GlcCer-transfer protein FAPP2 (also
known as PLEKHA8) (ref. 1). However, themolecular determinants
of the FAPP2-mediated transfer of GlcCer from the cis-Golgi to the
trans-Golgi network, as well as the physiological relevance of main-
taining twoparallel transportpathwaysofGlcCer—vesicular andnon-
vesicular—through the Golgi, remain poorly defined. Here, using
mouse and cellmodels, we clarify themolecularmechanisms under-
lying the intra-Golgi vectorial transfer of GlcCer by FAPP2 and
show thatGlcCer is channelled by vesicular andnon-vesicular trans-
port to two topologically distinct glycosylation tracks in the Golgi
cisternae and the trans-Golgi network, respectively. Our results
indicate that the transport modality across the Golgi complex is a
key determinant for the glycosylation pattern of a cargo and estab-
lish a new paradigm for the branching of the glycosphingolipid
synthetic pathway.
Complex glycosphingolipids (GSLs), which have key roles in cell
signalling, adhesion, proliferation and differentiation2, are synthesized
in the Golgi complex from GlcCer, which is synthesized from ceramide
at the cytosolic leaflet of early Golgi membranes3,4. Upon transloca-
tion to the luminal leaflet, GlcCer is galactosylated to lactosylceramide
(LacCer), which can then be converted into complex GSLs in later Golgi
compartments (Fig. 1a)5. GlcCer can be transported through the Golgi
complex via membrane trafficking and via non-vesicular transfer owing
to the action of the cytosolic GlcCer-transfer protein FAPP2, which
fosters GSL synthesis1,6. However, the respective roles of the vesicular
and non-vesicular transport of GlcCer remain to be defined7.
We have addressed this question by assessing the consequences of
FAPP2 gene ablation in mice (Fig. 1b–d and Supplementary Fig. 1a).
FAPP22/2 mice showed no overt phenotype. However, measurement
of GSL levels in the kidneys, where FAPP2 is highly expressed (Fig. 1b
and Supplementary Fig. 1b), highlighted a specific decrease in the glo-
boside series of GSL, in particular in globotriaosylceramide (Gb3), in
FAPP22/2 mice (Fig. 1e). Visualization of GSLs using the Shiga toxin B
fragment (ShTxB) that binds Gb3 (ref. 8), the cholera toxin B fragment
(ChTxB) that binds monosialotetrahexosylganglioside (GM1) (ref. 9),
and anti-monosialodihexosylganglioside (GM3) antibodies confirmed
the previously reported distribution ofGb3 in themouse kidney10,11 and
showed a selective reduction of Gb3 staining in the FAPP22/2 kidneys
(Fig. 1f, g) and in kidney tubular cells isolated from FAPP22/2 mice
(Supplementary Fig. 2).
Thus, FAPP2, in line with its rather recent evolutionary appearance
coincident with the divergence of multiple GSL branches12, selectively
controls one GSL branch in vivo. We then performed the analysis of
GSL in cells knocked down for FAPP2 by short interfering RNA
(siRNA) treatment (Supplementary Fig. 3). As reported previously1,
FAPP2 knockdown induced a 40% decrease in the levels of total GSLs
(taken as the sum of LacCer, GM3 and Gb3) but, considering the
individual GSL species, it lowered the levels of LacCer and Gb3 but
not GM3 (Fig. 2a). In agreement with these biochemical measure-
ments, a selective decrease in ShTxB staining was also observed in
FAPP2 knockdown cells (Supplementary Fig. 4a).
When we analysed the impact of FAPP2 knockdown on newly
synthesizedGSLs in 3H-sphingosine-labelledHeLa cells, we found that
FAPP2 depletion inhibited the synthesis of 3H-LacCer and 3H-Gb3 at
all time points (Fig. 2b and Supplementary Fig. 4b). FAPP2 knock-
down, however, also inhibited the synthesis of 3H-GlcCer at early time
points, in agreement with previous results1, and as a consequence
lowered the levels of 3H-GM3 (Fig. 2b and Supplementary Fig. 4b).
To circumvent changes in complex GSLs that might be secondary to
the inhibition of GlcCer synthesis, we bypassed GlcCer synthesis
by labelling the cells with fluorescent GlcCer (C12 BODIPY-GlcCer).
Under these conditions, FAPP2 depletion selectively inhibited the syn-
thesis of C12-BODIPY-Gb3 but not of C12-BODIPY-GM3 (Fig. 2c),
indicating that thedecrease inGb3butnot inGM3synthesiswas a direct
consequence of FAPP2 depletion. Systematic silencing of enzymes
involved in GSL biosynthesis (Figs 1a, 2d and Supplementary Fig. 4c, d)
highlighted that the GSL profile induced by FAPP2 silencing was sim-
ilar to that induced by LacCer synthase (LCS) silencing in terms of a
decrease in LacCer, but they differed in their effects on downstream
GSL species: LCS knockdown induced a uniform decrease in Gb3 and
GM3 whereas FAPP2 knockdown selectively decreased Gb3. These
results indicate that the GlcCer transported via FAPP2 feeds a pool
of LacCer specifically destined to globoside (that is, Gb3) synthesis.
Dynamic assessment of GSL metabolic fluxes followed by mathemat-
ical modelling corroborated this conclusion (Supplementary Fig. 5).
To search for the mechanisms responsible for the different sensiti-
vities of Gb3 and GM3 synthesis to FAPP2 depletion, we studied the
intra-Golgi distribution of Gb3 synthase (Gb3S) and of GM3 synthase
(GM3S) by two independent approaches7. First, we measured the syn-
thesis of Gb3 and GM3 in cells treated with brefeldin A (BFA), a toxin
that redistributes the Golgi cisternae (but not the trans-Golgi network
(TGN)) into the endoplasmic reticulum (ER) (generating an ER–Golgi
intermixed compartment), interrupts vesicular trafficking from this
intermixed compartment to the TGN13, and releases FAPP2 from
Golgi membranes14. BFA treatment decreased the synthesis of Gb3
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Figure 1 | FAPP2 selectively controls the levels of globosides in vivo.
a, Simplified representation of theGSL synthetic pathway in vertebrates. GA2S,
GA2 synthase; GCS, GlcCer synthase; LC3S, LC3 synthase. b, Expression of
FAPP2 in mouse tissues. c, Southern blot of wild-type (FAPP21/1) and
recombinant (FAPP2geo/1 and FAPP2geo/geo) mice tail DNA. See
Supplementary Fig. 1b. d, FAPP2 levels in FAPP21/1 and FAPP22/2 testes and
kidneys. e, Phospholipid (PL) and sphingolipid (SL) mass-spectrometry
analysis, and GSL measurements of kidneys from FAPP21/1 (n5 5) and
FAPP22/2 (n5 10) mice. Ganglio1, 2, unidentified gangliosides; Gb4,
globoside; GM2, monosyalotrihexosylceramide; PtdCho, phosphatidylcholine;
PtdIns, phosphatidylinositol; PtdEtn, phosphatidylethanolamine; PtdGly,
phosphatidylglycine; PtdSer, phosphatidylserine; SM, sphingomyelin.
Means6 s.e.m. f, ChTxB, ShTxB anti-GM3 staining of FAPP21/1 and
FAPP22/2 kidney cortex sections. Representative pictures from at least five
FAPP21/1 and five FAPP22/2 mice. Scale bars, 50mm. *P, 0.05;
***P, 0.005.
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Figure 2 | FAPP2 is selectively required for Gb3
synthesis. a, GSL levels in HeLa cells. KD,
knockdown; X, unassigned anionic GSL. b, High-
performance thin-layer chromatography (HPTLC)
profile of 3H-sphingosine-labelled HeLa cells.
Arrows denote changes induced by FAPP2
knockdown. Numbers represent the percentage of
each GSL species on total sphingolipids. c, HPTLC
profile of C12-BODIPY-GlcCer-labelled HeLa
cells. Arrows denote GSLs reduced by FAPP2
knockdown; # represents unassigned peak and
numbers represent the percentage of each GSL
species on total GSL. A.U., arbitrary units. d, Effect
of silencing of FAPP2 and of GSL synthetic
enzymes on GSL species (expressed as percentage
of total GSLs). Numbers represent the percentage
of total GSLs on total sphingolipids. Means6 s.d.
of at least three independent experiments.
*P, 0.05; **P, 0.01.
LETTER RESEARCH
5 S E P T E M B E R 2 0 1 3 | V O L 5 0 1 | N A T U R E | 1 1 7
Macmillan Publishers Limited. All rights reserved©2013
but not that of GM3, indicating that the main fraction of endogenous
Gb3S (but not of GM3S) resides in the TGN and thus remains segre-
gated from its substrates that are synthesized in the BFA-induced
intermixed ER–Golgi compartment (Fig. 3a). Second, we analysed
the distribution of GM3S and Gb3S (Fig. 3b, c). In agreement with
previous reports6,15, we found that Gb3S is enriched in the TGN
whereas GM3S is enriched in theGolgi cisternae.Moreover, consistent
with its effect on GSL synthesis (Fig. 3a), BFA redistributedGM3S, but
not Gb3S, to the ER (Supplementary Fig. 6).
The analysis of the role of FAPP2 was extended to other cell lines
that also synthesize more complex gangliosides that, like GM3, were
insensitive to FAPP2 depletion (Supplementary Fig. 7).
Thus, the synthesis of globosides at the TGN relies on the non-
vesicular transport of GlcCer operated by FAPP2, whereas the syn-
thesis of GM3 in the Golgi cisternae does not, eliciting the question as
to whether GM3 synthesis depends instead on the vesicular transport
of GlcCer. To address this question we inhibited intra-Golgi mem-
brane trafficking1 by treating cells with dicoumarol1, by depleting the
TRAPP component BET3 (also known as TRAPPC3) (ref. 1), or by
depleting cytosolic phospholipase A2 (cPLA2) (ref. 16), and followed
the transport of the temperature-sensitive mutant of vesicular stomat-
itis virus G protein (ts045-VSVG)14. As reported previously1,16, these
treatments suppressed the intra-Golgi progression of VSVG and
strongly inhibited GM3 synthesis, but not Gb3 synthesis (Fig. 3d, e).
These results led us to propose that the vesicular transport of GlcCer
feeds a pool of LacCer that is made in the Golgi cisternae and used for
GM3 biosynthesis, whereas the non-vesicular transport of GlcCer via
FAPP2 feeds a pool of LacCer that ismade in the TGN and used in this
compartment for globoside synthesis. This hypothesis generated some
key predictions: (1) LCS should be present not only in the Golgi
cisternae but also in the TGN; (2) other LacCer derivatives that, simi-
larly to Gb3, are made at the TGN should depend on FAPP2; and (3)
shifting the localization of GM3S from the Golgi cisternae to the TGN
shouldmake GM3 synthesis sensitive to FAPP2 depletion.We verified
all of these predictions. First, LCSwas found to localize both to theGolgi
cisternae and to the TGN (Supplementary Fig. 8); second, FAPP2
knockdown in SK-N-MC human neuronal cells selectively lowered the
synthesis of gangliotriosylceramide (GA2), which is made in the TGN
from LacCer (Fig. 1a and Supplementary Fig. 9a); third, GM3 syn-
thesis, which is normally insensitive, becomes sensitive to FAPP2 dep-
letion when a substantial fraction of GM3S is forced to localize at the
TGNbyexpressing the enzymeathigh levels (SupplementaryFig. 9b–d).
The selective requirement of FAPP2 for GSLs synthesized at the
TGN, together with our previous observation that cells depleted of
FAPP2 fail to concentrate GlcCer at the TGN1, indicate that FAPP2
drives the transfer of GlcCer from the cis-Golgi—where GlcCer is syn-
thesized—to the TGN, and raises the question of how this vectorial
transport is sustained. We reasoned that in order to mediate the cis-
Golgi-to-TGN transfer, apo-FAPP2 should be targeted to early Golgi
membranes whereas GlcCer-bound FAPP2 should be targeted to the
TGN.Thus,wecompared thedistributionofwild-type FAPP2with that
of a FAPP2mutant, which is unable to bind GlcCer and thus is perma-
nently apo (FAPP2(W407A))1. Although themain fractionofwild-type
FAPP2 localizes at the TGN, the main fraction of FAPP2(W407A)
localizes to the Golgi cisternae (Fig. 4a, b). Moreover, wild-type FAPP2
failed to localize at theTGNandwaspresentmainly in theGolgi cisternae
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Figure 3 | Vesicular GlcCer transport feeds GM3 synthesis in the Golgi
cisternae, whereas non-vesicularGlcCer transport feedsGb3 synthesis in the
TGN. a–c, Effect of BFA (5mgml21) on Gb3 and GM3 synthesis
(a). Distribution of haemagglutinin (HA)–Gb3S and HA–GM3S evaluated by
immunofluorescence (b) and by immunoelectron microscopy (c).
In b, top panels represent untreated cells and bottom panels represent
nocodazole-treated cells (3 h, 33mM). Insets: enlargement of the boxed areas.
The co-localization of HA–Gb3S and HA–GM3S with TGN46 was 50% and
14%, respectively. Data are representative of at least 30 cells per condition.
Scale bar, 10mm. c, Arrows represent clathrin-coated profiles at the
TGN. Data are representative of at least 30 stacks. Scale bar, 100nm.
d, e, Effect of intra-Golgi trafficking blockage onVSVG transport (means6 s.d.
in three independent experiments for at least 100 cells per time point)
(d) and on GM3 and Gb3 synthesis (3-h 3H-sphingosine pulse)
(e). Means6 s.d. of three independent experiments. DIC, dicoumarol
(200mM); GC, Golgi complex; PM, plasma membrane. *P, 0.05;
**P, 0.01; ***P, 0.005.
RESEARCH LETTER
1 1 8 | N A T U R E | V O L 5 0 1 | 5 S E P T E M B E R 2 0 1 3
Macmillan Publishers Limited. All rights reserved©2013
in cells that do not synthesize GlcCer17, where FAPP2 is always apo
(Fig. 4c). These results suggested that GlcCer binding positively regulates
the targeting of FAPP2 to the TGN.
FAPP2 localization at the TGN is determined by its pleckstrin homo-
logy (PH)domain that coincidentally and independently18 binds the small
GTPase ARF1 and phosphatidylinositol 4-phosphate (PtdIns4P)14, a
phosphoinositide enriched at the TGN19. Single pointmutations either
in the PtdIns4P14 or in the ARF-binding site18 (Supplementary Fig. 10)
abolish the recruitment of the PHdomain to theGolgi complex (ref. 14
and data not shown), indicating a requirement for both binding sites.
Interestingly, however, when these mutations are introduced into tan-
dem forms of the FAPP PH-domain (di-PH), such that the di-PH has
two binding sites either forARF (di-PH-R18L) or for Ptdins4P (di-PH-
E50A), the chimaeric proteins are able to localize to theGolgi complex,
although with significantly different intra-Golgi distributions. In par-
ticular, a mutant FAPP-PH domain with a lower affinity for PtdIns4P
and a higher affinity for ARF1 (di-PH-R18L) distributes throughout
the Golgi stacks14, whereas a mutant FAPP-PH domain with a lower
affinity for ARF1 and a higher affinity for PtdIns4P (di-PH-E50A)18
preferentially localizes to the TGN (Supplementary Fig. 10b), indi-
cating that PtdIns4P dictates the TGN targeting of FAPP2.
We therefore assessed whether the preferential TGN association of
GlcCer-boundFAPP2 could be due to the fact that it has a higher affinity
for PtdIns4P. We found indeed that GlcCer loading (Supplementary
information and Supplementary Fig. 11) increased FAPP2 binding to
PtdIns4P (Fig. 4d), whereas it did not significantly affect the ability to
bind ARF1 in vitro (not shown).
As FAPP2 binds GlcCer through its carboxy-terminal GLTP homo-
logy (GLTPH) domain1,20 and PtdIns4P through its amino-terminal
PH domain14, the increase in PtdIns4P affinity induced by GlcCer bind-
ing suggested that GlcCer binding triggers a conformational change
that is not limited to the GLTPH domain but is transmitted to more
N-terminal regions. To gain insight into these conformational changes,
we probed FAPP2byhydrogen-deuterium exchangemass spectrometry
(HDX-MS)21. The general profile of HDX-MS of FAPP2 indicated the
presence of scarcely solvent-accessible N-terminal and C-terminal
regions, corresponding to the PH-domain and the GLTPH domain,
and the presence of a highly accessible and flexible intervening linker
region (Fig. 4e). We then analysed the effects of GlcCer binding on the
HDX-MS profile of FAPP2 and integrated this analysis with that of
controlled proteolysis of FAPP2. The results of these analyses (Fig. 4f
and Supplementary Figs 12 and 13) showed that the binding of GlcCer
not only induced a stabilization of the GLTPH domain of FAPP2 but
also affected the linker region interposed between the GLTPH domain
and the PH domain, and on the PH domain itself, thus possibly having
an impact on its PtdIns4P binding.
At this point a ‘FAPP2 cycle’ can be delineated (Fig. 4g): apo-FAPP2
associates with the cis-Golgi where it acquires GlcCer, resulting in a
higher affinity of FAPP2 for PtdIns4P. FAPP2 then relocates to the
PtdIns4P-enriched TGN where it delivers GlcCer.
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arrows, targeting of apo-FAPP2 to theGolgi cisternae; cyan arrows, targeting of
GlcCer-bound FAPP2 to the TGN.).
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Our findings establish a new paradigm for GSL biosynthesis
whereby two branches receive their common precursor, GlcCer, from
two parallel transport routes (Fig. 4g): the vesicular route feeds the
LacCer pool used to make the ganglio-series in the Golgi cisternae,
whereas the non-vesicular route mediated by FAPP2, which bypasses
the intervening cisternae and delivers GlcCer to the TGN, feeds a TGN
pool of LacCer converted in loco intoGSLs of the globo- or asialo-series
(Figs 1a and 4g). In a wider context, our results show how different
modes of transporting a cargo through the Golgi complex channel the
cargo itself towards distinct and otherwise potentially competing gly-
cosylation pathways.
METHODS SUMMARY
FAPP22/2 mice were obtained following the procedure described in Supplemen-
tary Data and in ref. 22. High-performance liquid chromatography-based GSL
measurements, metabolic labelling with 3H-sphingosine, GSL extraction andHPTLC
and analysis, aswell as immunofluorescence and immunoelectronmicroscopy studies
for subcellular protein localization assessments, were performed as described in ref. 1.
Transport of ts045-VSVGwas assessed as described previously23. Protein purification,
fluorescence, circular dichroism and surface plasmon resonance studies were per-
formed as described in refs 24, 25.HDX-MSwas performed as in ref. 26. For statistical
analysis, two-tailed Student t-tests were applied to the data. *P,0.05; **P,0.01;
***P,0.005.
Full Methods and any associated references are available in the online version of
the paper.
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METHODS
Reagents and antibodies.All chemical reagents were of analytical grade or higher
and purchased from Sigma unless otherwise specified. Cell culture media were
from Invitrogen. Polyclonal antibodies against human FAPP2, BET3, cPLA2IVa
and GM130 were raised in rabbits using glutathione S-transferase fusion proteins
as immunogens. All were affinity purified on their corresponding immunogens.
The anti-VSVG clone P5D4, anti-Flag M2 and anti-HA monoclonal antibodies,
and the anti-rabbit and anti-mouse IgG Cy3-conjugated antibodies were from
Sigma. The Alexa 488-conjugated ChTxB fragment was from Invitrogen. The
Cy3-conjugated ShTxB fragment was prepared as described27. The mouse mono-
clonal antibody against GM3 (clone 2590) was from Cosmo Bio Co. Sheep poly-
clonal antibodies against TGN46 were from AbD Serotech. The Alexa 488 goat
anti-mouse and anti-rabbit IgG antibodies were fromMolecular Probes. All unla-
belled purified lipids were from Avanti Polar Lipids. 3H-sphingosine was from
PerkinElmer. Stock solutions of GSLs were prepared in chloroform/methanol (2:1
by volume) and of other lipids in hexane/2-propanol (3:2 by volume). Lipid solu-
tions were stored in the dark at 220 uC and warmed to room temperature before
use.
FAPP2 Knockout mice. Mice were from the C57BL/6 strain. All animal proce-
dures were performed in accordance with the guidelines of the Animal Care and
Experimentation Committee of Gunma University, and all animals were bred in
the Institute of Animal Experience Research of GunmaUniversity. FAPP2 knock-
out mice were generated following the procedure described in Supplementary
information. Histological, immunofluorescence microscopy and X-gal staining
were performed as previously described22,28,29.
Cell culture. HeLa, Meb4, GM95, HepG2, HK2, COS7 and MDCK cells were
grown and transiently transfected by TransIT-LT1 (Mirus Bio) as described in
ref. 1. Stably-expressing HeLa-GM3S cells were obtained after transfection of the
33HA–GM3S coding plasmid and selection in the presence of G418 (Invitrogen)
and screening of monoclonal colonies by indirect immunofluorescence.
Plasmids and constructs.Most of the constructs used in this study were obtained
from HeLa RNA by RT–PCR and cloning into appropriate vectors. In brief, total
RNA was isolated fromHeLa cells; RT–PCR was performed using a poly dT oligo
as a primer. The complementary DNA obtained was used as a template for PCR,
using the following primers: for Gb3S: forward 59-GTTGAATTCGATCTGG
GGATACCATGTCC-39, reverse 59-CACCTCGAGCAAGTACATTTTCATGG
CCTC-39; for GM3S: forward 59-CAGGAATTCAGAATGAGAAGGCCCA
GCTTGTTA-39, reverse 59-AACGCGGCCGCTGAAATTCACGATCAATGC
CTCCA-39; for LCS: forward 59-ATAGAATTCTGGCTGCAGCATGCGCGC-
39, reverse 59-CGCGATATCAAGTACTCGTTCACCTGAGCCA-39. The PCR
products were cloned into a linearized pCR2.1 vector, and processed for automatic
sequencing. All of the cloned sequences matched the sequence reported in data-
bases for human Gb3S (AF513325), GM3S (AY152815.2) and LCS (B4GALT5;
(NM_004776)). The DNAs corresponding to the various coding sequences were
then subcloned into EcoRI/XhoI (Gb3S), EcoRI/NotI (GM3S), EcoRI/EcoRV sites
of pCDNA3-3XHA at C-terminus or p3XFLAG-CMV-14.
Green fluorescent protein (GFP)–FAPP2 wild-type and W407A constructs
were obtained as described in ref. 1; recombinant GST–FAPP2 wild-type, GST–
FAPP2(W407A), His-FAPP2 wild type and His-FAPP2(W407A) were produced
in Escherichia coli as described in ref. 1.
GFP–diFAPP2PH-wild type and E50A were obtained as follows: GFP–FAPP2
wild-type DNA was used as a template for two distinct PCR reactions using as
primers: PCR (a): 59-TCTGAATTCATGGAGGGGGTGCTGTACA-3, 59-TAT
GGTACCGAGCAAGCAAGCCTTGGCTGATCCC-3; PCR (b): 59-TATGGT
ACCTTGCTGGAGGGGGTGCTGTACAAGTG-3, 59-TCACTCGAGTTAGCA
AGCCTTGGCTGATCC-3. Products from PCR (a) were subcloned into EcoRI/
KpnI sites of vector pEGFP-C1 to obtain construct pEGFP-FAPP2PH. Sub-
sequently, products from PCR (b) were subcloned into KpnI/XhoI sites of the
pEGFP-FAPP2PH construct to obtain GFP–diFAPP2PH-wild type. A similar
procedure was applied to obtain the GFP–diFAPP2PH(E50A) mutant using as
a template GFP–FAPP2(E50A) DNA. GFP–FAPP2(E50A) was obtained from
wild-type GFP–FAPP2 by site-directed mutagenesis using the primers 59-
GAGCATACAAATGGCAGTCTGTGCAATTCAAGTTCATTCTGTAG-39 and
59-CTACAGAATGAACTTGAATTGCACAGACTGCCATTTGTATGCTC-39.
siRNA treatments. The siRNAs for human FAPP2 (NM_001197026), GCS
(NM_003358), BET3 (NM_014408), B4GALT5 (NM_004776), B4GALT6
(NM_004775), SIAT9/GM3S (AY152815.2),A4GALT/Gb3S (NM_017436), PLA2
(NM_001199562) comprised mixtures of at least three siRNA duplexes (Sup-
plementary Table 1) and were obtained from Dharmacon. HeLa, HK2, HepG2
and MDCK cells were plated at 30% confluence in 12-well plates and transfected
with 120–150 pmol of siRNAs with Oligofectamine (Invitrogen) or Dharmafect4
(Dharmacon), in accordance with the manufacturer’s protocol. At 72 h after the
initial treatmentwith siRNA, the cells were processed directly. Silencing efficiency
was evaluated either by western blot (Supplementary Fig. 2) or by quantitative
PCR (Supplementary Fig. 4b) using specific primers (Supplementary Table 1).
Measurement of GSLs.Metabolic labelling with 3H-sphingosine or 14C-galactose,
GSL extraction and HPTLC and analysis were performed as described in refs 1, 6.
Immunofluorescence and morphometric analysis. All immunofluorescence
experimentswere performedasdescribedpreviously1,14. Images are confocal optical
slices obtained using an LSM 710 (Zeiss) confocal microscope. Co-localization
analysis was performed as described in ref. 14 or by using an object-based co-
localization method included in the JACoP v2.0 application for ImageJ30. In brief,
individualmini-stacks innocodazole-treated cells were considered as objectswhose
mass-centre position was calculated after segmentation. The perfect coincidence of
mass-centre positions for two distinct labellings (that is, Gb3S/TGN46 or GM3S/
TGN46) in a single mini-stack was considered as a positive co-localization event.
Immunoelectron microscopy. Immunoelectron microscopy was performed in
transfected HeLa, Meb4 and GM95 cells as described previously1.
VSVG intracellular transport assay. Transport of ts045-VSVG was assessed as
described previously23.
Statistical analysis. For statistical analysis, two-tailed Student t-tests were applied
to the data. *P, 0.05; **P, 0.01; ***P, 0.005.
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